SEC Company Response from PLIANT THERAPEUTICS, INC. (PLRX) (CIK 0001746473) (PLRX) — May 29, 2020
PLIANT THERAPEUTICS, INC. (PLRX) (CIK 0001746473)
Date: May 29, 2020 · CIK: 0001746473 · Accession: 0001193125-20-155676
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-238146
Letter
May 29, 2020
United States Securities and Exchange Commission
Office of Life Sciences
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Donald Field
Justin Dobbie
Re: Pliant Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-238146)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between May 26, 2020 and the date hereof, approximately 400 copies of the Preliminary Prospectus dated May 26, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, June 2, 2020 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
CITIGROUP GLOBAL MARKETS INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 29, 2020 United States Securities and Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Donald Field Justin Dobbie Re: Pliant Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-238146) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between May 26, 2020 and the date hereof, approximately 400 copies of the Preliminary Prospectus dated May 26, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, June 2, 2020 or as soon thereafter as practicable. [Signature page follows] Very truly yours, CITIGROUP GLOBAL MARKETS INC. COWEN AND COMPANY, LLC PIPER SANDLER & CO. As representatives of the Underwriters By: Citigroup Global Markets Inc. By: /s/ Bradley Wolff Name: Bradley Wolff Title: Managing Director By: Cowen and Company, LLC By: /s/ William Follis Name: William Follis Title: Managing Director By: Piper Sandler & Co. By: /s/ Chad Huber Name: Chad Huber Title: Managing Director [Signature page to Underwriters’ Acceleration Request]